Anthony Behin Selected Research

Nondystrophic myotonia

11/2021

Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony Behin Research Topics

Disease

9	Muscular Diseases (Myopathy) 01/2020 - 06/2011
6	Myasthenia Gravis 01/2023 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 07/2011
4	Myositis (Idiopathic Inflammatory Myopathies) 09/2012 - 09/2009
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 02/2010
3	Myofibrillar Myopathy 06/2018 - 03/2009
2	Muscle Weakness 01/2023 - 01/2019
2	Thymoma (Thymic Carcinoma) 01/2023 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 08/2015
2	Atrophy 01/2022 - 01/2020
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2019 - 01/2018
2	Dropped Head Syndrome 10/2017 - 10/2008
2	Disease Progression 04/2015 - 08/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2015 - 08/2013
2	Distal Myopathies (Distal Muscular Dystrophy) 06/2011 - 11/2009
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2024
1	Rare Diseases (Rare Disease) 01/2023
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2023
1	Left Ventricular Dysfunction 01/2023
1	Deglutition Disorders (Dysphagia) 01/2022
1	Dysarthria (Spastic Dysarthria) 01/2022
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2022
1	Hypertrophy 01/2022
1	Myotonic Disorders (Paramyotonia Congenita) 11/2021
1	Nondystrophic myotonia 11/2021
1	Myotonia Congenita (Thomsen Disease) 11/2021
1	Myotonia 11/2021
1	COVID-19 10/2021
1	Oral Ulcer (Mouth Ulcer) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Inclusion Body Myositis 01/2021
1	Dysferlinopathy 01/2021
1	Camptocormia 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Brody myopathy 01/2020
1	Bundle-Branch Block (Fascicular Block) 01/2018
1	Glycogen Storage Disease Type III (Cori's Disease) 11/2017
1	Melanoma (Melanoma, Malignant) 10/2017
1	Fatigue 10/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Pain (Aches) 10/2017
1	Channelopathies 06/2017
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 06/2017
1	Cerebellar Ataxia (Dysmetria) 06/2017
1	Ataxia (Dyssynergia) 06/2017
1	Respiratory Insufficiency (Respiratory Failure) 08/2015
1	Hypercapnia 08/2015
1	Polymyositis 05/2015
1	Myalgia 05/2015

Drug/Important Bio-Agent (IBA)

7	AutoantibodiesIBA 01/2023 - 07/2011
6	AntibodiesIBA 01/2023 - 09/2009
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2009
4	Cholinergic ReceptorsIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 05/2015
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 07/2011
2	AcidsIBA 01/2022 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2021 - 01/2021
2	DesminIBA 06/2018 - 11/2009
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 01/2003
2	Rituximab (Mabthera)FDA Link 05/2015 - 09/2009
1	Antisense OligonucleotidesIBA 01/2024
1	nusinersenIBA 01/2024
1	ConnectinIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	EnzymesIBA 01/2022
1	GlucosidasesIBA 01/2022
1	Mexiletine (Mexitil)FDA LinkGeneric 11/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	ametantrone (HAQ)IBA 01/2021
1	CalciumIBA 01/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019
1	Protein AggregatesIBA 06/2018
1	DystrophinIBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2018
1	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 11/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017
1	Immune Checkpoint InhibitorsIBA 10/2017
1	VemurafenibIBA 10/2017
1	cobimetinibIBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017
1	tributyl phosphate (TBP)IBA 06/2017
1	polyglutamineIBA 06/2017

Therapy/Procedure

6	Therapeutics 11/2018 - 02/2010
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 08/2015
2	Radiotherapy 10/2008 - 01/2003
1	Spinal Injections 01/2024
1	Activities of Daily Living (ADL) 01/2023
1	Gastrostomy 01/2022
1	Glossectomy 01/2022
1	Speech Therapy (Therapy, Speech) 01/2022
1	Nutritional Support (Artificial Feeding) 01/2022
1	Continuous Positive Airway Pressure 01/2022
1	Organ Transplantation 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Thymectomy 11/2018